Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Cell Neurosci ; 29(3): 372-80, 2005 Jul.
Article in English | MEDLINE | ID: mdl-15950153

ABSTRACT

The transcription factor ATF5 is expressed in cells of the embryonic and neonatal ventricular zone/subventricular zone (VZ/SVZ), and must be down-regulated for their differentiation into neurons and astrocytes. Here, we show that ATF5 plays a major role in directing oligodendrocyte development. ATF5 is expressed by oligodendrocyte precursors but is absent from mature oligodendroglia. Constitutively expressed ATF5 maintains SVZ cells and O4(+) oligodendrocyte precursors in cycle and inhibits their differentiation into oligodendrocytes in vitro and in vivo. In contrast, ATF5 loss-of-function (LOF; produced by a dominant-negative form of the protein) accelerates oligodendrocyte differentiation of O4(+) cells in vitro and of SVZ cells in vivo. Significantly, the accelerated oligodendrocyte differentiation promoted by ATF5 LOF in vivo results in aberrant migration. Thus, appropriately regulated expression of ATF5 is required for proper expansion of oligodendroglial progenitors as well as for their timely differentiation. Regulation of oligodendrocyte, astrocyte, and neuronal differentiation indicates that ATF5 operates as a general regulator of the timing of differentiation, independent of cell lineage.


Subject(s)
Cell Differentiation/genetics , Cell Proliferation , Oligodendroglia/metabolism , Prosencephalon/growth & development , Stem Cells/metabolism , Transcription Factors/metabolism , Animals , Animals, Newborn , Astrocytes/cytology , Astrocytes/metabolism , Cell Cycle Proteins/genetics , Cell Cycle Proteins/metabolism , Cell Lineage/physiology , Cell Movement/physiology , Cells, Cultured , Down-Regulation/physiology , Gene Expression Regulation, Developmental/physiology , Mutation/physiology , Neurons/cytology , Neurons/metabolism , Prosencephalon/cytology , Prosencephalon/metabolism , Rats , Stem Cells/cytology , Transcription Factors/genetics
2.
J Neurosci ; 25(15): 3889-99, 2005 Apr 13.
Article in English | MEDLINE | ID: mdl-15829641

ABSTRACT

The mechanisms that regulate neural progenitor cell differentiation are primarily unknown. The transcription factor activating transcription factor 5 (ATF5) is expressed in neural progenitors of developing brain but is absent from mature astrocytes and neurons. Here, we demonstrate that ATF5 regulates the conversion of ventricular zone (VZ) and subventricular zone (SVZ) neural progenitors into astrocytes. Constitutive ATF5 expression maintains neural progenitor cell proliferation and blocks their in vitro and in vivo differentiation into astrocytes. Conversely, loss of ATF5 function promotes cell-cycle exit and allows astrocytic differentiation in vitro and in vivo. CNTF, a promoter of astrocytic differentiation, downregulates endogenous ATF5, whereas constitutively expressed ATF5 suppresses CNTF-promoted astrocyte genesis. Unexpectedly, constitutive ATF5 expression in neonatal SVZ cells both in vitro and in vivo causes them to acquire properties and anatomic distributions of VZ cells. These findings identify ATF5 as a key regulator of astrocyte formation and potentially of the VZ to SVZ transition.


Subject(s)
Activating Transcription Factors/metabolism , Astrocytes/metabolism , Cell Differentiation/physiology , Down-Regulation/physiology , Neurons/metabolism , Stem Cells/physiology , Activating Transcription Factors/genetics , Animals , Animals, Newborn , Astrocytes/drug effects , Brain/anatomy & histology , Brain/metabolism , Bromodeoxyuridine/metabolism , Cell Count/methods , Cell Differentiation/drug effects , Cells, Cultured , Ciliary Neurotrophic Factor/pharmacology , Down-Regulation/drug effects , Embryo, Mammalian , Glial Fibrillary Acidic Protein/metabolism , Green Fluorescent Proteins/biosynthesis , Immunohistochemistry/methods , Intermediate Filament Proteins/metabolism , Ki-67 Antigen/metabolism , Microscopy, Confocal/methods , Models, Anatomic , Nerve Tissue Proteins/metabolism , Nestin , Neural Cell Adhesion Molecule L1/pharmacology , Neurons/drug effects , RNA, Messenger/metabolism , RNA, Small Interfering/pharmacology , Rats , Rats, Sprague-Dawley , Reverse Transcriptase Polymerase Chain Reaction/methods , Sialic Acids/pharmacology , Stem Cells/drug effects , Transfection/methods , Tubulin/metabolism , beta Catenin/metabolism
3.
Am J Pathol ; 164(5): 1673-82, 2004 May.
Article in English | MEDLINE | ID: mdl-15111314

ABSTRACT

To understand mechanisms that may underlie the progression of a demyelinated lesion to a chronic state, we have used the cuprizone model of chronic demyelination. In this study, we investigated the fate of oligodendrocytes during the progression of a demyelinating lesion to a chronic state and determined whether transplanted adult oligodendrocyte progenitors could remyelinate the chronically demyelinated axons. Although there is rapid regeneration of the oligodendrocyte population following an acute lesion, most of these newly regenerated cells undergo apoptosis if mice remain on a cuprizone diet. Furthermore, the oligodendrocyte progenitors also become progressively depleted within the lesion, which appears to contribute to the chronic demyelination. Interestingly, even if the mice are returned to a normal diet following 12 weeks of exposure to cuprizone, remyelination and oligodendrocyte regeneration does not occur. However, if adult O4+ progenitors are transplanted into the chronically demyelinated lesion of mice treated with cuprizone for 12 weeks, mature oligodendrocyte regeneration and remyelination occurs after the mice are returned to a normal diet. Thus, the formation of chronically demyelinated lesions induced by cuprizone appears to be the result of oligodendrocyte depletion within the lesion and not due to the inability of the chronically demyelinated axons to be remyelinated.


Subject(s)
Demyelinating Diseases/pathology , Oligodendroglia/metabolism , Animals , Antigens/chemistry , Apoptosis , Axons/metabolism , Cell Death , Cell Differentiation , Corpus Callosum/pathology , Cuprizone/pharmacology , Disease Progression , Glutathione Transferase/metabolism , Immunohistochemistry , Lectins/chemistry , Macrophages/metabolism , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Microglia/metabolism , Myelin Sheath/chemistry , Oligodendroglia/chemistry , Protein Isoforms , Proteoglycans/chemistry , RNA/chemistry , Recombinant Fusion Proteins/metabolism , Stem Cells/metabolism , Time Factors
4.
Neuron Glia Biol ; 1(3): 179-92, 2004 Aug.
Article in English | MEDLINE | ID: mdl-18634596

ABSTRACT

To ensure rapid and efficient impulse conduction, myelinated axons establish and maintain specific protein domains. For instance, sodium (Na+) channels accumulate in the node of Ranvier; potassium (K+) channels aggregate in the juxtaparanode and neurexin/caspr/paranodin clusters in the paranode. Our understanding of the mechanisms that control the initial clustering of these proteins is limited and less is known about domain maintenance. Correlative data indicate that myelin formation and/or mature myelin-forming cells mediate formation of all three domains. Here, we test whether myelin is required for maintaining Na+ channel domains in the nodal gap by employing two demyelinating murine models: (1) cuprizone ingestion, which induces complete demyelination through oligodendrocyte toxicity; and (2) ceramide galactosyltransferase deficient mice, which undergo spontaneous adult-onset demyelination without oligodendrocyte death. Our data indicate that the myelin sheath is essential for long-term maintenance of sodium channel domains; however, oligodendrocytes, independent of myelin, provide a partial protective influence on the maintenance of nodal Na+ channel clusters. Thus, we propose that multiple mechanisms regulate the maintenance of nodal protein organization. Finally, we present evidence that following the loss of Na+ channel clusters the chronological progression of expression and reclustering of Na+ channel isoforms during the course of CNS remyelination recapitulates development.

5.
J Neurosci ; 23(20): 7710-8, 2003 Aug 20.
Article in English | MEDLINE | ID: mdl-12930811

ABSTRACT

We examined the role of IGF signaling in the remyelination process by disrupting the gene encoding the type 1 IGF receptor (IGF1R) specifically in the mouse brain by Cre-mediated recombination and then exposing these mutants and normal siblings to cuprizone. This neurotoxicant induces a demyelinating lesion in the corpus callosum that is reversible on termination of the insult. Acute demyelination and oligodendrocyte depletion were the same in mutants and controls, but the mutants did not remyelinate adequately. We observed that oligodendrocyte progenitors did not accumulate, proliferate, or survive within the mutant mice, compared with wild type, indicating that signaling through the IGF1R plays a critical role in remyelination via effects on oligodendrocyte progenitors.


Subject(s)
Myelin Sheath/physiology , Oligodendroglia/physiology , Receptor, IGF Type 1/metabolism , Signal Transduction , Animals , Cells, Cultured , Central Nervous System/physiology , Corpus Callosum/cytology , Corpus Callosum/drug effects , Corpus Callosum/physiology , Cuprizone/toxicity , Macrophages/cytology , Mice , Mice, Transgenic , Microglia/cytology , Mutation , Oligodendroglia/cytology , Oligodendroglia/metabolism , Receptor, IGF Type 1/genetics , Somatomedins/physiology , Stem Cells/cytology , Stem Cells/metabolism , Stem Cells/physiology , Tumor Necrosis Factor-alpha/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...